Know Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% – Still a Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW) traded up 3.8% during trading on Wednesday . The stock traded as high as $2.17 and last traded at $2.1390. 612,050 shares traded hands during trading, an increase of 60% from the average session volume of 381,756 shares. The stock had previously closed at $2.06.

Know Labs Price Performance

The stock has a fifty day simple moving average of $2.14 and a two-hundred day simple moving average of $2.14. The firm has a market capitalization of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83.

Institutional Trading of Know Labs

Several hedge funds have recently modified their holdings of KNW. Bard Financial Services Inc. acquired a new position in shares of Know Labs during the 3rd quarter valued at $80,000. Corient Private Wealth LLC acquired a new stake in Know Labs in the second quarter worth $99,000. Finally, Cerity Partners LLC bought a new stake in Know Labs in the second quarter valued at $158,000. Institutional investors own 23.96% of the company’s stock.

Know Labs Company Profile

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.